Iradimed (IRMD) Share-based Compensation Growth (1y) (2014 - 2026)
Iradimed (IRMD) Share-based Compensation Growth (1y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.95 Bn | 193.35 Bn | 7.27 Bn | 18.31% |
| 2 | Stryker | 128.10 Bn | 124.63 Bn | 4.50 Bn | -78.13% |
| 3 | Medtronic | 118.91 Bn | 109.69 Bn | 6.41 Bn | 6.74% |
| 4 | Boston Scientific | 73.43 Bn | 72.89 Bn | 3.85 Bn | 16.00% |
| 5 | Edwards Lifesciences | 51.91 Bn | 47.66 Bn | 1.35 Bn | 12.53% |
| 6 | Dexcom | 34.52 Bn | 32.58 Bn | 830.00 Mn | -13.91% |
| 7 | GE HealthCare Technologies | 33.94 Bn | 31.83 Bn | 2.18 Bn | 60.71% |
| 8 | Koninklijke Philips | 26.37 Bn | 23.05 Bn | 4.55 Bn | 5.29% |
| 9 | Steris | 23.14 Bn | 22.66 Bn | 684.20 Mn | 7.56% |
| 10 | Iradimed | 1.12 Bn | 1.06 Bn | 15.16 Mn | 10.45% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 10.45% |
| Mar 31, 2026 | 489.66% |
| Dec 31, 2025 | 12.56% |
| Sep 30, 2025 | 5.73% |
| Jun 30, 2025 | 19.95% |
| Mar 31, 2025 | -81.55% |
| Dec 31, 2024 | 21.41% |
| Sep 30, 2024 | 18.03% |
| Jun 30, 2024 | 7.15% |
| Mar 31, 2024 | 1,160.41% |
| Dec 31, 2023 | 359.24% |
| Sep 30, 2023 | 35.75% |
| Jun 30, 2023 | 369.79% |
| Mar 31, 2023 | -89.00% |
| Dec 31, 2022 | -70.21% |
| Sep 30, 2022 | 8.66% |
| Jun 30, 2022 | -66.20% |
| Mar 31, 2022 | 1,071.26% |
| Dec 31, 2021 | 350.34% |
| Sep 30, 2021 | -13.13% |